Discover Altasciences’ Clinical Trial Site Solutions
Altasciences' Clinical Trial Site Solutions provides a strategic advantage for your projects.
Benefit from:
- Diverse Patient Populations: Access our global network of specialized sites for challenging research projects.
- Expert Site Identification and Oversight: Leverage our high-recruitment partner sites, historical data, and dedicated project managers for efficient trial management.
- Tailored Support: Reduce potential challenges with our comprehensive site evaluation, which includes experienced physicians in your target therapeutic area able to provide valuable feedback on protocol design.
- Streamlined Operations: Experience expedited site selection, budget negotiations, and investigator grant payments.
Ready to discover the advantages of Altasciences' Clinical Trial Site Solutions?
Four Pain Models Altasciences Uses to Assess Treatments During Clinical Trials
September is pain awareness month, and the importance of pain management and continued research into effective analgesics is integral to helping patients suffering from various pain conditions.
Critical Considerations for the Manufacture of Highly Potent Compounds
The demand for highly potent active pharmaceutical ingredients (HPAPIs) has been increasing over the past decade, mainly driven by oncology research.
In this issue, we examine the intricacies of manufacturing HPAPIs and associated drug products, including a review of the relevant guidance, classification systems, and safety processes. We also explore how CDMO facilities, equipment, and procedures for HPAPIs should be adapted to ensure safety, compliance with GMP regulations, and the successful manufacture of your product.
READ THE ISSUE
Related resources that may interest you:
Webpage: High Potency Manufacturing Services
Webinar: Nanosuspension Formulations for Poorly Soluble Drugs
Interview: Handling Your Highly Potent APIs and Controlled Substances
Manufacturing With a Highly Potent API for an Ophthalmic Indication
All Things Oligonucleotides!
The therapeutic development of antisense oligonucleotides (ASOs) has expanded its reach to encompass diseases like Huntington's, Alzheimer's, and Parkinson's.
Given their ability to pinpoint disease pathogenesis's root cause, ASOs are a hopeful avenue for addressing stubborn illnesses and genetic disorders.
Explore our resource library to learn more about oligonucleotides and their potential, from synthesis techniques to innovative applications.
Poster Presentations:
Application of Mitra Microsampling for the Quantitative Bioanalysis of ASOs
Development of a Surrogate Cerebrospinal Fluid Matrix for Quantitative Analysis of ASOs by Hybridization LC-MS
Development of an Oligonucleotide Drug Immunogenicity Assay
eBook:
Bioanalytical Development for the Analysis of ASOs
Special Issue of The Altascientist:
Antisense Oligonucleotides (with two case studies!)
Research Articles:
Accurate Quantification of ASOs in Mouse Serum Using Microsampling LC-MS/MS
Altasciences has been recognized as a 2023 CRO Leadership Award Champion in the Capabilities category, as voted by you in ISR’s annual CRO Quality Benchmarking survey.
Altasciences' Facilities: Moving in Unison
Embarking on a Career in Drug Development
Getting to the Heart of Science with Amber malloy
